C12Y 101/01141
15-hydroxyprostaglandin dehydrogenase
Official title: 15-Hydroxyprostaglandin dehydrogenase (NAD+) (1.1.1.141)
C12Y101/01141 (15-hydroxyprostaglandin dehydrogenase) appears on 0 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 0
- Published applications
- 4
- Assignees
- 1
- Inventors
- 13
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 2 |
By publication year.
Recent patents
No granted patents in this class yet.
- Engineered oncolytic herpesviruses13 Feb 2025US 2025/0049867 A1
- Regeneration or rejuvenation of tissues and organs2 Jan 2025US 2025/0002919 A1The Board of Trustees of the Leland Stanford Junior University
- Methods and compositions for improving neuromuscular junction morphology and function26 Dec 2024US 2024/0423964 A1The Board of Trustees of the Leland Stanford Junior University
- Rejuvenation of aged tissues by inhibition of the pge2 degrading enzyme, 15-pgdh6 Jul 2023US 2023/0210829 A1The Board of Trustees of the Leland Stanford Junior University
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.